Pulmonary Cell News Volume 12.20 | May 25 2023

    0
    17







    2023-05-25 | PULCN 12.20


    Pulmonary Cell News by STEMCELL Technologies
    Vol. 12.20 – 25 May, 2023
    TOP STORY

    Tenascin-C Activation of Lung Fibroblasts in a 3D Synthetic Lung Extracellular Matrix Mimic

    Researchers developed a synthetic, bioactive hydrogel that mimicked the native lung modulus and included a representative distribution of the most abundant extracellular matrix peptide motifs, which enabled quiescent culture of human lung fibroblasts.
    [Advanced Materials]

    Abstract
    An ISSCR 2022 COREdinates Webinar: Differentiation of High-Quality hPSCs Using STEMdiff â„¢ and TeSR â„¢-AOF, presented by Kim Snyder. Click to Watch Now.
    PUBLICATIONSRanked by the impact factor of the journal

    CEACAM6 as a Novel Therapeutic Target To Boost HO-1-Mediated Antioxidant Defense in COPD

    Scientists investigated the defense mechanisms against nitrosative/oxidative stress that could prevent COPD development or progression.
    [American Journal Of Respiratory And Critical Care Medicine]

    Abstract

    Globoside and the Mucosal pH Mediate Parvovirus B19 Entry Through the Epithelial Barrier

    MDCK II cells and well-differentiated human airway epithelial cell cultures were grown on porous membranes and used as models to study the interaction of B19V with the epithelial barrier.
    [PLOS Pathogens]

    Full Article

    RTK Signaling Promotes Epithelial Columnar Cell Shape and Apical Junction Maintenance in Human Lung Progenitor Cells Icon for the Forest of Biologists

    Investigators used the organoid system to identify signaling pathways that maintained the columnar shape of human lung tip progenitors. They found that EGF, FGF7, and FGF10 had distinct functions in lung tip progenitors.
    [Development]

    Abstract

    Rad1 Attenuates DNA Double-Strand Breaks and Cell Cycle Arrest in Type II Alveolar Epithelial Cells of Rats With Bronchopulmonary Dysplasia

    The accumulation of DNA double-strand breaks in primary type II alveolar epithelial cells might be an important cause of alveolar growth arrest associated with bronchopulmonary dysplasia (BPD). Rad1 could be an effective target for intervention to improve this arrest in lung development associated with BPD.
    [Molecular Medicine]

    Full Article

    SERS Endoscopy for Monitoring Intracellular Drug Dynamics

    Researchers reported the application of surface-enhanced Raman scattering (SERS) endoscopy, using plasmonic nanowires as SERS probes, to monitor the intracellular fate and dynamics of a common chemo-drug, doxorubicin, in A549 cancer cells.
    [2D Materials]

    Full ArticleGraphical Abstract

    KRASG12C Mutation-Induced TOPK Overexpression Contributes to Tumor Progression in Non-Small Cell Lung Cancer

    The overexpression of T-LAK cell-originated protein kinase (TOPK) significantly promoted the malignant phenotype of A549 cells, and TOPK silencing impaired the malignant phenotype with KRASG12C mutation.
    [Journal Of Cellular And Molecular Medicine]

    Full Article

    Dual Inhibition of IDO1/TDO2 Enhances Anti-Tumor Immunity in Platinum-Resistant Non-Small Cell Lung Cancer

    Scientists reported that JWA was significantly downregulated in smoking-related lung cancer and associated with overall survival.
    [Cancer & Metabolism]

    Full ArticleGraphical Abstract

    Synthesis, Characterization and Biological Activity of Novel Copper Complexes Containing a β-Carboline Derivative and Amino Acids

    The antitumor activity of two novel copper(II) complexes containing a β-carboline derivative and amino acids against lung cancer cells, cervical cancer cells, and breast cancer cells was significantly superior to that of the traditional antitumor drug, cisplatin.
    [Dalton Transactions]

    AbstractGraphical Abstract
    Survey results on the needs and challenges in the human pluripotent stem cell field
    REVIEWS

    Nano-Mediated Strategy for Targeting and Treatment of Non-Small Cell Lung Cancer (NSCLC)

    The authors discuss the potential of stimuli-responsive nanomaterials for drug delivery in lung cancer and the limitations and opportunities for improving the design of nano-based materials for the treatment of NSCLC.
    [Naunyn-Schmiedebergs Archives Of Pharmacology]

    Abstract
    INDUSTRY AND POLICY NEWS

    Immutep Announces Promising New Clinical Data From Triple Combination Therapy in INSIGHT-003 Trial

    Immutep, Ltd. announced new encouraging clinical data in first-line NSCLC from INSIGHT-003, an investigator-initiated Phase I trial conducted by the Frankfurt Institute of Clinical Cancer Research IKF.
    [Immutep, Ltd.]

    Press Release
    FEATURED EVENT

    The Aging Genome: From Mechanisms to Disease

    June 4 – 7, 2023
    Heidelberg, Germany

    > See All Events

    JOB OPPORTUNITIES

    Research Technician – Pulmonary Fibrosis

    MGH Institute of Health Professions – Boston, Massachusetts, United States

    Staff Assistant – Pulmonary Medicine

    Rutgers University – New Brunswick, New Jersey, United States

    Researcher – Pediatrics Allergy & Pulmonary Medicine

    University of Washington – Medical Lake, Washington, United States

    Postdoctoral Research Associate – Oncology

    St. Jude Children’s Research Hospital – Memphis, Tennessee, United States

    Postdoctoral Fellow – Cancer Biology

    Wake Forest University – Winston Salem, North Carolina, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Pulmonary Cell News Twitter